Close Menu

NEW YORK (360Dx) – Researchers in New Zealand have reported that an Abbott point-of-care assay that measures troponin concentration can rule out acute myocardial infarction and produce a test result in 15 minutes from a single sample with discrimination capability comparable to that of a high-sensitivity troponin laboratory assay.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.